Lightnews — Scholar-powered news

apwiita.bsky.social @apwiita.bsky.social · May 16

‼️Preprint‼️ CD22 CAR Ts are cooked - time to move on to CD72. Adila Izgutdina and fantastic collaborators show CD72 is likely a better second-line antigen than CD22 for CD19-refractory B-ALL/B-NHL. Excited to bring CD72 “nanoCARs” to the clinic @ucsfhealth.bsky.social. www.biorxiv.org/content/10.1...

Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies

Background: Chimeric antigen receptor (CAR) T-cell therapies are highly efficacious for several different hematologic cancers. However, for most CAR T targets it is observed that low surface antigen d...

www.biorxiv.org

1 1

apwiita.bsky.social @apwiita.bsky.social · Mar 21

This is possibly the dumbest idea I’ve ever seen decrypt.co/311027/meme-...

Will further undermine trust in science by strengthening links to 1) memecoins and 2) blatantly abused system of bringing questionable “supplements” to consumers with no FDA oversight. Please shut this down immediately.

Can a Meme Coin Fund the Future of Scientific Research? - Decrypt

Pump.Science’s decentralized model aims to reshape scientific funding and support longevity research, but challenges remain.

decrypt.co

Reposted

Corynn Kasap MD PhD @corynnkasap.bsky.social · Mar 7

Amazing turnout at today’s #StandUpForScience in San Francisco

4 28

apwiita.bsky.social @apwiita.bsky.social · Mar 7

STAND UP FOR SCIENCE!✊🏽💪

Great turnout in #SanFrancisco to defend science from political attacks. Funding science is what actually makes America great vehicle for economic growth, advances in innovation, American leadership, upward mobility for Americans, and overall benefit to humanity.

1 2